Cargando…
DNA Methylation as a Therapeutic Target for Bladder Cancer
Bladder cancer (BC) is the tenth most frequent cancer worldwide and is associated with high mortality when diagnosed in its most aggressive form, which is not reverted by the current treatment options. Thus, the development of new therapeutic strategies, either alternative or complementary to the cu...
Autores principales: | Nunes, Sandra P., Henrique, Rui, Jerónimo, Carmen, Paramio, Jesús M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463638/ https://www.ncbi.nlm.nih.gov/pubmed/32784599 http://dx.doi.org/10.3390/cells9081850 |
Ejemplares similares
-
Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
por: Lodewijk, Iris, et al.
Publicado: (2021) -
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
por: Constâncio, Vera, et al.
Publicado: (2020) -
EZH2 in Bladder Cancer, a Promising Therapeutic Target
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015) -
Cell Therapies in Bladder Cancer Management
por: Morales, Lucia, et al.
Publicado: (2021) -
Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer
por: Flores, Bianca C. T., et al.
Publicado: (2021)